Hepatoblastoma - 20 Studies Found
| Completed |
: A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB :
: Drug: LDE225 LDE225/sonidegib capsules were supplied to the Investigators at dose strengths of 50 mg, 10 |
| Not yet recruiting |
: G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor :
|
| Active, not recruiting |
: Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia :
|
| Completed |
: Auto Transplant for High Risk or Relapsed Solid or CNS Tumors :
|
| Withdrawn |
: Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors :
|
| Completed |
: Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors :
|
| Active, not recruiting |
: Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors :
|
| Completed |
: A Phase II Trial of Reduced Intensity Conditioning and Haploidentical BMT for High-risk Solid Tumors : Refractory and/or Relapsed Metastatic Solid Tumors : 2013-03-01 :
|